[Clinical evaluation of low dose glucocorticoid therapy for hormone-refractory prostate cancer].

Kobayashi, T; Jo, Y; Ikegami, M; Furukawa, Y; Morioka, M; Tanaka, H; Kinugawa, K; Ohta, S

Kobayashi, T; Jo, Y; Ikegami, M; Furukawa, Y; Morioka, M; Tanaka, H; Kinugawa, K; Ohta, S.

Affiliation

Kobayashi T; Department of Urology, Kawasaki Medical School.

Nihon Hinyokika Gakkai Zasshi ; 91(4): 479-84, 2000 Apr.

Article in Ja | MEDLINE | ID: mdl-10826247

Subject(s)

Antineoplastic Agents, Hormonal/administration & dosage; Dexamethasone/administration & dosage; Glucocorticoids/administration & dosage; Prednisolone/administration & dosage; Prostatic Neoplasms/drug therapy; Aged; Aged, 80 and over; Biomarkers, Tumor/blood; Drug Administration Schedule; Drug Therapy, Combination; Gonadotropin-Releasing Hormone/analogs & derivatives; Humans; Male; Middle Aged; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Quality of Life; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Dexamethasone / Prednisolone / Antineoplastic Agents, Hormonal / Glucocorticoids Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Aged / Aged80 / Humans / Male / Middle aged Language: Ja Journal: Nihon Hinyokika Gakkai Zasshi Year: 2000 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links